Skip navigation
Skip navigation

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

Grimison, Peter S; Stockler, Martin R; Thomson , Damien B; Olver, Ian N; Harvey, Vernon J; Gebski, Val J; Lewis, Craig R; Levi, John A; Boyer, Michael J; Gurney, Howard; Craft, Paul; Boland, Amy L; Simes, R John; Toner, Guy C


Background The Australian and New Zealand Germ Cell Trials Group conducted a multicenter randomized phase III trial in men with good-prognosis germ cell tumors of two standard chemotherapy regimens that contained bleomycin, etoposide, and cisplatin but differed in the scheduling and total dose of cisplatin, the total dose of bleomycin, and the scheduling and dose intensity of etoposide. The trial was stopped early at a median follow-up of 33 months after a planned interim analysis found a...[Show more]

CollectionsANU Research Publications
Date published: 2010
Type: Journal article
Source: Journal of the National Cancer Institute
DOI: 10.1093/jnci/djq245


File Description SizeFormat Image
01_Grimison_Comparison_of_Two_Standard_2010.pdf387.09 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator